Denver's Kindman Cannabis Calls for Greater Transparency by Colorado Regulators, Following ...

Warning message

The subscription service is currently unavailable. Please try again later.

Some experts, meanwhile, hope Kindman will share the results of its Colorado Open Records Act request with the legal marijuana industry’s scientific community.

In the wake of a dispute over legal marijuana testing procedures and an announced recall, the founder of Denver-based Kindman cannabis is calling for greater transparency and collaboration between industry stakeholders and the state of Colorado regarding its testing protocols for marijuana products.

Last week the state’s Marijuana Enforcement Division (MED) said cannabis samples from Denver-based Kindman came back positive for trace amounts of a banned insecticide.

According to that announcement, samples of Kindman cannabis allegedly contained a detectable amount of imidacloprid, an insecticide commonly used in mainstream agriculture but banned last year by Colorado officials for use on cannabis. The MED also announced a recall of Kindman products going back two years.

Kindman CEO Ryan Fox denies imidiacloprid is used in his company’s cannabis...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.